Citalopram. Buspirone, The risk or severity of adverse effects can be increased when Buspirone is combined with Citalopram. Busulfan, The metabolism of
QIDS-SR-16 scores significantly decreased with citalopram and bupropion compared to citalopram and buspirone (p 0.02) by study endpoint. There were no significant differences in remission rates in citalopram and bupropion and citalopram and buspirone groups.
Buspirone See Are allergic to Buspirone, or any of the ingredients in Buspirone are allergic to Citalopram, or any of the ingredients in Citalopram
[ ] [ ] Citalopram: (Moderate) Coadministration of buspirone with citalopram may increase the risk of serotonin syndrome. Buspirone
QIDS-SR-16 scores significantly decreased with citalopram and bupropion compared to citalopram and buspirone (p 0.02) by study endpoint. There were no significant differences in remission rates in citalopram and bupropion and citalopram and buspirone groups.
Bupropion: 31.8% Buspirone: 26.9 %: Bupropion: 39% Buspirone: 32.9%: Not stated: QIDS-SR-16 scores significantly decreased with citalopram and bupropion compared to citalopram and buspirone (p 0.02) by study endpoint. There were no significant differences in remission rates in citalopram and bupropion and citalopram and buspirone groups
Buspirone: 40.9 Citalopram (with bupropion adjunct): 54.2 Citalopram (with Buspirone adjunct) 54.9: Nil: Open label, randomized (STAR D) 12: Bupropion: 31.8% Buspirone: 26.9 %: Bupropion: 39% Buspirone: 32.9%: Not stated: QIDS-SR-16 scores significantly decreased with citalopram and bupropion compared to citalopram and buspirone (p 0.02) by
QIDS-SR-16 scores significantly decreased with citalopram and bupropion compared to citalopram and buspirone (p 0.02) by study endpoint. There were no significant differences in remission rates in citalopram and bupropion and citalopram and buspirone groups.
citalopram and the 5-HT 1A receptor agonist buspirone is reported Combined serotonin syndrome and hyponatraemia caused by a citalopram-buspirone interaction.
Comments